Literature DB >> 2465155

Endocervical adenocarcinoma. Clinico-pathologic and histochemical study of 29 cases.

L Resta1, M D Scordari, R S Mastrogiulio, C Faggiano, L Sabatini, F Trimigliozzi, F Pascazio, L Loiudice.   

Abstract

Twenty-nine women were treated for endocervical adenocarcinoma in the University of Bari in the years 1975-1981. The histological type was "endocervical" or "mucinous" in 12 patients (41.4%), "endometrioid" in 12 (41.4%), "clear cell" in 2 (6.9%), "adenosquamous" in 2 (6.9%), and "serous" or "papillary" in 1. Foci of papillary and endometrioid metaplasia were present in 2 adenocarcinomas of endocervical type. The following histochemical methods were used: PAS reaction, PAS reaction with diastase predigestion, Bleu Alcian at pH 2.5 and pH 1, mucicarmine, Toluidine Bleu at 0.3%. The "endocervical" type adenocarcinoma showed mucicarmine positive and PAS positive, diastase resistant material in the whole cytoplasm. This material was not metachromatic and Bleu Alcian positive only in the well differentiated forms. In the "endometrial" adenocarcinoma only in the apex of the glandular cells was PAS positive diastase resistant, Alcian and mucicarmine positive. "Clear cell" and "adenosquamous" carcinomas showed only few cytoplasmatic PAS positive, diastase sensitive granules (= glycogen). No positivity was present in the "papillary" or "serous" carcinomas. Our results permit us to unify the histological and the histochemical patterns of the cervical adenocarcinomas and those of the similar forms of the endometrium and of the ovary, and stress the common müllerian origin of these neoplasms.

Entities:  

Mesh:

Year:  1989        PMID: 2465155

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  1 in total

1.  Meesmann corneal dystrophy; a clinico-pathologic, ultrastructural and confocal scan report.

Authors:  Mohammad-Ali Javadi; Mozhgan Rezaei-Kanavi; Atefeh Javadi; Nima Naghshgar
Journal:  J Ophthalmic Vis Res       Date:  2010-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.